Category: BA.1

Multiple hypermutated SARS-CoV-2 sequences that may have been created by molnupiravir

Molnupiravir, a drug used to treat SARS-CoV-2 infections, has received a lot of press attention since its launch, and not all of it has been positive.  More...

Coronaheadsup.com BA.1.1, BA.2.3, Coronavirus, Evolution, Genome, Health, Immunocompromised, Infection, Molnupiravir, Mutation, Omicron, Persistent Infection, Predictions, Research, Side Effects, Testing, Transmission, Variants

Spillover of new BA.1 sublineage from persistently infected COVID patient into the community

“The new BA.1 sub-lineage transmitted to five independent cases, including two reported in GISAID from a different surveillance effort”…

Gisaid: BA.1 sublineage with T6001C and S mutations: S:E96D, S:L167T, S:R346T, S:L455W, S:K458M, S:E484V, S:H681R, S:P688V, detected in New York, USA #663.  More...

Coronaheadsup.com America, BA.1, Coronavirus, Genome, Healthcare, Immunocompromised, Infection, New York State, Omicron, Preprint, Research, Spillover, Testing, USA

UK ONS: 2.7% of the British population reporting Long Covid symptoms

An estimated 1.7 million people living in private households in the UK (2.7% of the population) were experiencing self-reported long COVID as of 5 March 2022

The estimates presented in this analysis relate to self-reported long COVID, as experienced by study participants who responded to a representative survey, rather than clinically diagnosed ongoing symptomatic COVID-19 or post-COVID-19 syndrome in the full population.  More...

Coronaheadsup.com BA.1, BA.2, Children, Coronavirus, Delta, Elderly, England, Europe, Healthcare, Hospitalization, Infection, London, Long Covid, Mental Heath, Northern Ireland, Omicron, Recombinants, Scotland, Symptoms, Transmission, UK, Wales